MedTrace Logo

A Study to Evaluate Effectiveness and Safety of Tyrosine Kinase Inhibitors

NCT03424980 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2018-02-08

No results posted yet for this study

Summary

This is a real-world non-interventional observational study. The study was designed to evaluate the effectiveness and safety of clinical treatments in the patients with advanced non-small cell lung cancer (NSCLC) complicated with brain metastases in clinical practice.

Conditions

  • Non-small Cell Lung Cancer Metastatic

Interventions

COMBINATION_PRODUCT

Tyrosine kinase inhibitors

Tyrosine kinase inhibitors only or combinations therapies of tyrosine kinase inhibitors

Sponsors & Collaborators

  • LinkDoc Technology (Beijing) Co. Ltd.

    collaborator INDUSTRY

  • Tang-Du Hospital

    lead OTHER

Principal Investigators

  • Helong Zhang · Xi'an Tangdu Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-31
Primary Completion
2018-04-30
Completion
2018-04-30
FDA Drug
Yes

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03424980 on ClinicalTrials.gov